UB
TAK icon

UMB Bank’s Takeda Pharmaceutical TAK Stock Holding History

UMB Bank’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Hold
1,117
– – ﹤0.01% 1718
2026
Q1 		$20.7K Hold
1,117
– – ﹤0.01% 1592
2025
Q4 		$17.4K Buy
1,117
+710
+174% +$10.2K ﹤0.01% 1610
2025
Q3 		$5.96K Buy
407
+57
+16% +$846 ﹤0.01% 1837
2025
Q2 		$5.41K Hold
350
– – ﹤0.01% 1803
2025
Q1 		$5.21K Hold
350
– – ﹤0.01% 1748
2024
Q4 		$4.63K Buy
350
+124
+55% +$1.7K ﹤0.01% 1730
2024
Q3 		$3.21K Sell
226
-41
-15% -$582 ﹤0.01% 1854
2024
Q2 		$3.46K Sell
267
-267
-50% -$3.54K ﹤0.01% 1570
2024
Q1 		$7.42K Hold
534
– – ﹤0.01% 1329
2023
Q4 		$7.62K Sell
534
-990
-65% -$14K ﹤0.01% 1354
2023
Q3 		$23.6K Sell
1,524
-1,200
-44% -$18.6K ﹤0.01% 1036
2023
Q2 		$42.8K Hold
2,724
– – ﹤0.01% 880
2023
Q1 		$44.9K Buy
2,724
+1,306
+92% +$20.8K ﹤0.01% 863
2022
Q4 		$22K Sell
1,418
-1,477
-51% -$20.6K ﹤0.01% 1090
2022
Q3 		$37K Sell
2,895
-1,611
-36% -$22.4K ﹤0.01% 946
2022
Q2 		$64K Sell
4,506
-614
-12% -$8.77K ﹤0.01% 847
2022
Q1 		$74K Buy
5,120
+370
+8% +$5.43K ﹤0.01% 851
2021
Q4 		$65K Buy
+4,750
New +$66.6K ﹤0.01% 915

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

UMB Bank's TAK Position: Q2 2026 in Review

UMB Bank held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 1,117 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

UMB Bank first reported a position in TAK in Q4 2021 and has held it in 19 quarters since. The position peaked at $74K in Q1 2022. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • UMB Bank held 1,117 shares of Takeda Pharmaceutical worth $17.9K as of Q2 2026.
  • UMB Bank left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1718 holding.
  • UMB Bank first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Takeda Pharmaceutical position peaked at $74K in Q1 2022.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.